1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
A Swedish cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in the treatment of iron deficiency anemia in patients with inflammatory bowel disease
- Contribution to journal › Article
- 2023
-
Mark
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization : a European multinational economic evaluation
McEwan, Phil ; Harrison, Cale ; Binnie, Rhona ; Lewis, Ruth D. ; Cohen-Solal, Alain ; Lund, Lars H. ; Ohlsson, Marcus LU
; von Haehling, Stephan
; Comin-Colet, Josep
and Pascual-Figal, Domingo A.
, et al.
(2023)
In European Journal of Heart Failure
25(3).
p.389-398
- Contribution to journal › Article
- 2019
-
Mark
Rationale and design of the AFFIRM-AHF trial : a randomised, double-blind, placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on hospitalisations and mortality in iron-deficient patients admitted for acute heart failure
- Contribution to journal › Article
- 2013
-
Mark
Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life
- Contribution to journal › Article